Flu Drugs Show Promise in Reducing Cognitive Decline for HIV Patients
Flu drugs may reduce cognitive decline in people with HIV
Image: Medical News
A study from Northwestern University suggests that flu drugs may help reduce cognitive decline in individuals with HIV by preserving protective sugar molecules that combat inflammation. This research opens avenues for potential new therapies for cognitive issues related to aging and HIV.
- 01The study identifies the degradation of protective sugar molecules, known as glycans, as a key factor in cognitive decline among people with HIV.
- 02Flu drugs, specifically a combination of Tamiflu and another experimental drug, were shown to preserve glycans and reduce inflammation in preclinical trials.
- 03Cognitive impairment affects at least 25% of individuals living with HIV, even with effective antiretroviral treatment.
- 04The degradation of glycans was found to be more pronounced in women, particularly around menopause, leading to increased inflammation.
- 05Future research will focus on optimizing treatment strategies with flu drugs and developing blood biomarker tests to predict cognitive decline.
Advertisement
In-Article Ad
A recent study led by Northwestern University has revealed that a class of flu drugs may help mitigate cognitive decline in individuals living with HIV. The research, published in the journal Med, indicates that the degradation of protective sugar molecules, known as glycans, contributes to cognitive issues in HIV patients. By analyzing blood samples from over 100 individuals, researchers found a direct link between glycan degradation and cognitive impairment. In laboratory studies, a combination of Tamiflu and another experimental drug was effective in preserving these glycans, reducing inflammation, and protecting memory in mouse models. The findings suggest that flu drugs could be repurposed for cognitive complications associated with HIV and aging. Notably, the study found that the degradation of glycans was more pronounced in women, particularly around menopause, highlighting the need for gender-specific treatment approaches. The research team is now focused on optimizing treatment strategies and developing blood tests to predict cognitive decline.
Advertisement
In-Article Ad
This research could lead to new therapeutic strategies for cognitive decline in HIV patients, potentially improving their quality of life.
Advertisement
In-Article Ad
Reader Poll
Do you think flu drugs should be tested for cognitive decline in HIV patients?
Connecting to poll...
More about Northwestern University
Nueva terapia genética ofrece esperanza para tratar disquinesias en pacientes con Parkinson
Infobae • Jun 5, 2026
Breakthrough Study Reveals Winds from Milky Way's Supermassive Black Hole
Scientificamerican • Jun 4, 2026
Study Reveals Organized Microbial Guilds in Earth's Underground Biosphere
Phys.org • Jun 3, 2026
Read the original article
Visit the source for the complete story.